Idera Pharmaceuticals, Inc. (IDRA) Posts Narrower than Expected Q1 Loss

Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) reported Q1 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Idera Pharmaceuticals, Inc. (IDRA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Radnostix revenue falls 27% amid product recalls and FDA actions
• Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02